Effect of Oral Minoxidil on Monilethrix
March 2025
in “
International Journal of Trichology
”
New to Minoxidil? There is a guide in the encyclopedia. Read the guide → Studysummary This case report describes a 14-year-old female patient with monilethrix who developed female androgenetic alopecia at age 23, and found that oral minoxidil treatment improved her androgenetic alopecia while leaving the underlying structural hair anomalies of monilethrix unchanged.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document discusses a case study of a 14-year-old female with monilethrix, a genetic hair disorder characterized by fragile, beaded hair, who developed female androgenetic alopecia (AGA) at age 23. She was successfully treated with 1.25 mg oral minoxidil, which improved hair thickness and diversity of hair shaft diameters, although the structural anomaly of monilethrix persisted. The study highlights that while no specific treatment exists for monilethrix, minoxidil can be beneficial for comorbid AGA, enhancing hair length and thickness. The report emphasizes the importance of recognizing multiple causal relationships in hair disorders and the advantage of oral minoxidil in reducing trauma to fragile hair compared to topical applications.